Press Room


Esoteric Testing Market to exceed $35 billion by 2024

Esoteric Testing Market size is set to exceed USD 35 billion by 2024; according to a new research study published by Global Market Insights, Inc.
 

Growing demand for genomics and proteomics has led to a marked increase for genetic testing. Genetic testing is gaining popularity over the years due to rising prevalence of complex diseases such as muscular dystrophy, epilepsy, and Alzheimer's disease among others. Moreover, growing adoption of companion diagnostics due to rise in demand for targeted therapies for cancer treatment should also contribute to the esoteric testing market growth.
 

Implementation of advanced technologies such as bioinformatics and growing lab automation trend are other pivotal factors likely to propel the esoteric testing market growth. Tremendous increase in the use of nucleic acid and protein sequencing as well as rising collaborations between companies and research institutes has led to increased adoption of bioinformatics technology. Use of such advancements has made esoteric testing more efficient and accurate for disease diagnosis.

 

Request Sample Buy NowInquiry Before Buying

 

The shift in trend towards preventive disease management and identification of risk factors in the disease areas of endocrinology, oncology as well as reproduction health in women should further fuel the esoteric testing business growth. There has been an increased awareness among the physicians regarding the benefits of prescribing tests for early disease detection and prevention.
 

Strict regulatory framework, and unfavorable reimbursement scenario along with dearth of qualified technical personnel to operate specialized esoteric tests may restrain esoteric testing industry expansion during the forecast timeframe.
 

Browse key industry insights spread across 105 pages with 69 market data tables & 9 figures & charts from the report, “Esoteric Testing Market Size By Test Type (Endocrinology, Infectious Disease & Immunology, Oncology, Toxicology, Neurology, Genomics) By Technology (Mass Spectrometry, Flow Cytometry, ELISA, Radioimmunoassay, Chemiluminescence, Real Time-PCR) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE) Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/esoteric-testing-market

 

Oncology segment is slated to witness lucrative rate owing to increasing prevalence of cancer and introduction of number of esoteric tests such as PTEN/ERG FISH, and UroVysion FISH tests for detection of bladder cancer and assessment of treatment for prostate cancer. Moreover, increasing awareness regarding women reproductive health should also spur the demand for esoteric testing in oncology.
 

Genomics segment represents another promising area for growth in the coming years citing the dynamics the industry is witnessing. For instance, in May 2017, the U.S. FDA approved Merck’s Keytruda drug to treat cancer based on genetic defects rather than the organ or site of tumor. This has been possible due to availability of genetic testing to identify cancer causing abnormalities leading to an effective treatment plan. Thus esoteric tests in genomics are slated to gain market traction during the forecast period.
 

Chemiluminescence and ELISA technologies are the largest revenue generators in esoteric testing market owing the benefits offered along with high volume of tests conducted for the areas of infectious diseases and immunology.
 

Mass spectrometry is another technology which is anticipated to grow at rapid rate due to technological advancements in the field and increased usage of combined technologies such as tandem mass spectrometry and LC/MS in esoteric testing.
 

Europe esoteric testing market is predominantly driven by countries of Germany and UK. Increasing prevalence of cancer and growing demand for early detection are the major factors contributing to growth of esoteric testing market. Moreover, increased knowledge among the physicians regarding esoteric testing should further augment growth.
 

Japan was the largest esoteric testing market in Asia Pacific region, followed by China and India in 2016. The countries of China and India are slated to witness rapid growth in the coming years due to presence of large unmet needs in terms of large patient pool of infectious and immunological diseases, rising per capita income and development of healthcare infrastructure.
 

Prominent industry players include Laboratory Corporation of America, Quest Diagnostics, Opko Health Company, Arup Laboratories, Mayo Medical Laboratories, Myriad Genetics, Genomic Health, Invitae, BioMONTR, ACM Global Laboratories, and Nordic Laboratories. The major strategies adopted by the market players include mergers and acquisitions to expand geographical footprint and product offerings to stay ahead in the competitive market.
 

Esoteric testing market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:

Esoteric Testing Market by Test Type

  • Endocrinology
  • Infectious Disease & Immunology
  • Oncology
  • Toxicology
  • Neurology
  • Genomics
  • Others

Esoteric Testing Market by Technology

  • Mass Spectrometry
  • Flow Cytometry
  • ELISA
  • Radioimmunoassay
  • Chemiluminescence
  • Real Time-PCR
  • Others

The above information is provided for the following regions/countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE